Literature DB >> 31057687

Tracer Accumulation in Relation to Venous Thrombus on 18F-DOPA PET/CT in a Case of Persistent Hyperinsulinemic Hypoglycemia of Infancy.

Saurabh Arora1, Nishikant Avinash Damle1, Averilicia Passah1, Rajni Sharma2, Harish Goyal1, Shreedharan Thankarajan Arunraj1, Priyanka Gupta2, Manisha Jana3.   

Abstract

18F-DOPA PET/CT is commonly done in patients with persistent hyperinsulinemic hypoglycemia of infancy (PHHI) to look for any focal lesion in the pancreas. We present the findings in a 20-day-old neonate with PHHI who underwent 18F-DOPA PET/CT. The scan showed diffuse uptake in the pancreas with no focal lesion, physiologic excretion into the genito-urinary system, and interestingly tracer accumulation was seen in the inferior vena cava and ilio-femoral veins which is a non-physiological site for tracer accumulation. The uptake corresponded to a large venous thrombus which was confirmed by a venous Doppler.

Entities:  

Keywords:  18F-DOPA PET/CT; Congenital hyperinsulinism; Persistent hyperinsulinemic hypoglycemia of infancy (PHHI); Venous thrombus

Year:  2019        PMID: 31057687      PMCID: PMC6473011          DOI: 10.1007/s13139-018-00568-5

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  12 in total

Review 1.  Neonatal hypoglycemia.

Authors:  L Sann
Journal:  Biol Neonate       Date:  1990

2.  Current developments in imaging for deep vein thrombosis.

Authors:  Yolanda Lee
Journal:  Hong Kong Med J       Date:  2015-04       Impact factor: 2.227

Review 3.  The role of molecular imaging in diagnosis of deep vein thrombosis.

Authors:  Sina Houshmand; Ali Salavati; Søren Hess; Mudalsha Ravina; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

4.  Experimental infusion thrombophlebitis. A comparison between glucose and frutcose and 5% and 10% glucose solution.

Authors:  I Hessov; M Bojsen-Møller; F Melsen
Journal:  Intensive Care Med       Date:  1979-05       Impact factor: 17.440

Review 5.  Virchow's triad revisited: abnormal flow.

Authors:  Gordon D O Lowe
Journal:  Pathophysiol Haemost Thromb       Date:  2003 Sep-2004 Dec

6.  Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report.

Authors:  Marisa Miceli; Rola Atoui; Ronald Walker; Tahsine Mahfouz; Nadeem Mirza; Jose Diaz; Guido Tricot; Bart Barlogie; Elias Anaissie
Journal:  J Clin Oncol       Date:  2004-05-15       Impact factor: 44.544

7.  Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.

Authors:  Carmen Capito; Naziha Khen-Dunlop; Maria-João Ribeiro; Francis Brunelle; Yves Aigrain; Célia Crétolle; Francis Jaubert; Pascale De Lonlay; Claire Nihoul-Fékété
Journal:  Radiology       Date:  2009-08-25       Impact factor: 11.105

8.  Dopamine visualized in the basal ganglia of living man.

Authors:  E S Garnett; G Firnau; C Nahmias
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

9.  The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.

Authors:  Ryan S Youland; Gaspar J Kitange; Timothy E Peterson; Deanna H Pafundi; Judi A Ramiscal; Jenny L Pokorny; Caterina Giannini; Nadia N Laack; Ian F Parney; Val J Lowe; Debra H Brinkmann; Jann N Sarkaria
Journal:  J Neurooncol       Date:  2012-10-20       Impact factor: 4.130

10.  18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.

Authors:  Marguerite Meintjes; Raymond Endozo; John Dickson; Kjel Erlandsson; Khalid Hussain; Caroline Townsend; Leon Menezes; Jamshed Bomanji
Journal:  Nucl Med Commun       Date:  2013-06       Impact factor: 1.690

View more
  1 in total

Review 1.  Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis.

Authors:  Xiaoling Li; Nina C Weber; Danny M Cohn; Markus W Hollmann; J Hans DeVries; Jeroen Hermanides; Benedikt Preckel
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.